EdgarLookup

Sunshine Biopharma Inc. — All Filings

379 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-KT 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 10QSB/A 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-A12G 8-K 8-K/A CERT CORRESP D DEF 14A DEF 14C DEFA14A DEFR14C DEL AM EFFECT NT 10-K NT 10-Q POS AM PRE 14A PRE 14C REGDEX RW S-1 S-1/A S-3 S-4 S-8 SB-2 SC 13G SC 13G/A SC 14F1 SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K FORM 8-K 0001683168-26-001609 Mar 9, 2026 Mar 6, 2026
DEF 14C FORM DEF 14C 0001683168-26-001410 Mar 2, 2026
8-K CURRENT REPORT 0001683168-26-001216 Feb 20, 2026 Feb 18, 2026
PRE 14C PRELIMINARY INFORMATION STATEMENT 0001683168-26-001215 Feb 20, 2026 Feb 18, 2026
8-K CURRENT REPORT 0001683168-26-000789 Feb 5, 2026
8-K FORM 8-K 0001683168-25-009103 Dec 12, 2025 Dec 11, 2025
10-Q FORM 10-Q FOR SEP 2025 0001683168-25-008328 Nov 13, 2025 Sep 30, 2025
DEFA14A FORM DEFA 14A 0001683168-25-007749 Oct 23, 2025
DEF 14A DEFINITIVE PROXY 0001683168-25-007747 Oct 23, 2025 Dec 11, 2025
8-K CURRENT REPORT 0001683168-25-007338 Sep 30, 2025 Sep 24, 2025
SCHEDULE 13G/A 0002000324-25-002749 Aug 14, 2025
EFFECT 9999999995-25-002587 Aug 12, 2025
10-Q FORM 10-Q FOR JUN 2025 0001683168-25-005981 Aug 12, 2025 Jun 30, 2025
424B3 PROSPECTUS 0001683168-25-005978 Aug 12, 2025
RW FORM RW 0001683168-25-005976 Aug 12, 2025
UPLOAD 0000000000-25-008396 Aug 11, 2025
CORRESP 0001683168-25-005883 Aug 11, 2025
S-1 FORM S-1 0001683168-25-005644 Aug 5, 2025
POS AM POST-EFFECTIVE AMENDMENT #2 0001683168-25-005404 Jul 25, 2025
SCHEDULE 13G/A 0000921895-25-001755 Jun 12, 2025
SCHEDULE 13G 0001213900-25-047357 May 23, 2025
8-K CURRENT REPORT 0001683168-25-003838 May 19, 2025 May 15, 2025
10-Q FORM 10-Q FOR MAR 2025 0001683168-25-003701 May 15, 2025 Mar 31, 2025
SCHEDULE 13G 0000921895-25-001064 Apr 11, 2025
8-K CURRENT REPORT 0001683168-25-002245 Apr 3, 2025 Apr 2, 2025
424B5 424B5 0001683168-25-002241 Apr 3, 2025
8-K CURRENT REPORT 0001683168-25-002193 Apr 2, 2025 Apr 1, 2025
10-K FORM 10-K FOR DEC 2024 0001683168-25-002184 Apr 1, 2025 Dec 31, 2024
NT 10-K NT 10-K 0001683168-25-002126 Mar 31, 2025 Dec 31, 2024
SCHEDULE 13G/A 0001079973-25-000265 Feb 14, 2025
3 0001683168-25-000448 Jan 21, 2025 Jan 13, 2025
EFFECT 9999999995-25-000122 Jan 15, 2025
8-K CURRENT REPORT 0001683168-25-000357 Jan 15, 2025 Jan 13, 2025
CORRESP 0001683168-25-000288 Jan 13, 2025
UPLOAD 0000000000-25-000323 Jan 13, 2025
S-3 REGISTRATION STATEMENT 0001683168-25-000107 Jan 6, 2025
8-K CURRENT REPORT 0001683168-24-008607 Dec 10, 2024
SC 13G/A 0001172661-24-005249 Nov 14, 2024
424B4 FORM 424B4 0001683168-24-007865 Nov 12, 2024
EFFECT 9999999995-24-003412 Nov 8, 2024
8-K FORM 8-K 0001683168-24-007758 Nov 7, 2024 Nov 6, 2024
POS AM POS AM 0001683168-24-007657 Nov 6, 2024
10-Q FORM 10-Q FOR SEPT 2024 0001683168-24-007622 Nov 5, 2024 Sep 30, 2024
8-K CURRENT REPORT 0001683168-24-007323 Oct 23, 2024 Oct 21, 2024
DEF 14A DEFINITIVE PROXY STATEMENT 0001683168-24-007196 Oct 17, 2024 Dec 10, 2024
8-K FORM 8-K 0001683168-24-006281 Sep 10, 2024 Sep 9, 2024
10-Q/A FORM 10-Q/A 0001683168-24-005931 Aug 20, 2024 Jun 30, 2024
8-K FORM 8-K 0001683168-24-005903 Aug 19, 2024
10-Q FORM 10-Q 0001683168-24-005846 Aug 16, 2024 Jun 30, 2024
NT 10-Q REQUEST FOR EXTENSION 0001683168-24-005691 Aug 14, 2024 Jun 30, 2024